On the other hand, the observed stronger anti-S1 (s)IgA response in the saliva of previously infected vaccinees – likely generated by re-activation of infection-induced local (s)IgA+ memory B cells – might explain their recently described higher protection from infection and spreading (16, 17, 70). The gene discussed is CD79A; the disease is infection.